AMNEAL PHARMACEUTICALS INC's ticker is and the CUSIP is 03168L905. A total of 3 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40 | +344.4% | 9,500 | +43.9% | 0.00% | – |
| Q1 2023 | $9 | -57.1% | 6,600 | -37.7% | 0.00% | – |
| Q4 2022 | $21 | -99.9% | 10,600 | -10.2% | 0.00% | – |
| Q3 2022 | $23,000 | -23.3% | 11,800 | +21.6% | 0.00% | – |
| Q2 2022 | $30,000 | +20.0% | 9,700 | +56.5% | 0.00% | – |
| Q1 2022 | $25,000 | -44.4% | 6,200 | -35.4% | 0.00% | – |
| Q4 2021 | $45,000 | +462.5% | 9,600 | +464.7% | 0.00% | – |
| Q3 2021 | $8,000 | +60.0% | 1,700 | +70.0% | 0.00% | – |
| Q2 2021 | $5,000 | -83.3% | 1,000 | +2073.9% | 0.00% | – |
| Q1 2021 | $30,000 | -11.8% | 46 | -39.5% | 0.00% | – |
| Q4 2020 | $34,000 | +183.3% | 76 | +130.3% | 0.00% | – |
| Q3 2020 | $12,000 | – | 33 | +3200.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
| Q1 2020 | $124,000 | +629.4% | 357 | +864.9% | 0.00% | – |
| Q4 2019 | $17,000 | -71.7% | 37 | -82.2% | 0.00% | – |
| Q3 2019 | $60,000 | -54.2% | 208 | +13.7% | 0.00% | – |
| Q2 2019 | $131,000 | +6450.0% | 183 | +9050.0% | 0.00% | – |
| Q1 2019 | $2,000 | -98.7% | 2 | -97.1% | 0.00% | – |
| Q3 2018 | $150,000 | +476.9% | 68 | +325.0% | 0.00% | – |
| Q2 2018 | $26,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 33 | $12,000 | 0.00% |